FINWIRES · TerminalLIVE
FINWIRES

$BLLN

15 stories mentioning BLLNUpdated 5d ago

Every FINWIRES story that references BLLN, newest first.

What are analysts saying about BLLN?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on BLLN?

Insider Trading

BillionToOne Insider Sold Shares Worth $3,030,444, According to a Recent SEC Filing

Oguzhan Atay, Director, Chairman and Chief Executive Officer, on September 14, 2026, sold 30,331 shares in BillionToOne (BLLN) for $3,030,444. Following the Form 4 filing with the SEC, Atay has control over a total of 157,168 Class A common shares of the company, with 157,168 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000208854926000010/xslF345X05/wk-form4_1789598628.xml

$BLLN
Insider Trading

Billiontoone Insider Sold Shares Worth $1,975,400, According to a Recent SEC Filing

David Tsao, Director, Chief Technology Officer, on September 09, 2026, sold 20,000 shares in Billiontoone (BLLN) for $1,975,400. Following the Form 4 filing with the SEC, Tsao has control over a total of 1,000 Class A common shares of the company, with 1,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000208712726000011/xslF345X05/wk-form4_1789164088.xml

$BLLN
Research

Canaccord Genuity Initiates BillionToOne at Buy With $120 Price Target

BillionToOne (BLLN) has an average rating of buy and mean price target of $119.75, according to analysts polled by FactSet.

$BLLN
Wire

BillionToOne Launches New Liquid Biopsy Test to Help Identify Tissue of Origin

BillionToOne (BLLN) has launched Northstar Origin, a new liquid biopsy add-on test that predicts tissue of origin directly from circulating cell-free DNA for patients with cancer of unknown primary or uncertain cancer diagnosis, the company said Tuesday.The molecular diagnostics company said it has also expanded its Northstar Select panel to 102 genes from 84, to cover genes that are included in recent and upcoming US Food and Drugs Administration approvals.Price: $91.49, Change: $+0.81, Percent Change: +0.90%

$BLLN
Insider Trading

Billiontoone Insider Sold Shares Worth $2,331,352, According to a Recent SEC Filing

Oguzhan Atay, Director, Chairman, and CEO, on August 05, 2026, sold 15,539 shares in Billiontoone (BLLN) for $2,331,352.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000208854926000007/xslF345X05/wk-form4_1786132943.xml

$BLLN
Wire

Top Midday Decliners

BillionToOne (BLLN) reported Q2 earnings late Wednesday, but the swing from a loss a year ago was weaker than forecast.Shares slumped 39% as intraday trading volume jumped to over 2.70 million from a daily average of about 746,000.Onterris' (ONT) outlook weakened as the environmental services company cut its 2026 earnings before interest, taxes, depreciation, and amortization guidance amid likely pressure from deregulation and softer emergency-response activity, BofA Securities said in a report Thursday.Shares sank 35%, with intraday trading volume rising to over 1.67 million from a daily average of roughly 692,000.YXT.com (YXT) said Thursday that certain institutional investors have agreed to purchase 150,000 American depositary shares at an offering price of $7 each, resulting in about $1.05 million in gross proceeds to the company.Shares plunged 66% as intraday trading volume catapulted to over 2.84 million from a daily average of about 28,000.Price: $14.70, Change: $-7.94, Percent Change: -35.06%

$BLLN$ONT$YXT
Insider Trading

BillionToOne Insider Sold Shares Worth $6,167,960, According to a Recent SEC Filing

Oguzhan Atay, Director, Chairman and Chief Executive Officer, on August 03, 2026, sold 45,000 shares in BillionToOne (BLLN) for $6,167,960. Following the Form 4 filing with the SEC, Atay has control over a total of 162,500 Class A common shares of the company, with 162,500 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000207084926000052/xslF345X05/wk-form4_1785977563.xml

$BLLN
Insider Trading

Billiontoone Insider Sold Shares Worth $560,840, According to a Recent SEC Filing

Shan Riku Sakakibara, Chief Product Officer, on July 31, 2026, sold 4,000 shares in Billiontoone (BLLN) for $560,840. Following the Form 4 filing with the SEC, Sakakibara has control over a total of 200,000 Class A common shares of the company, with 200,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000208854726000008/xslF345X05/wk-form4_1785875561.xml

$BLLN
Insider Trading

BillionToOne Insider Sold Shares Worth $1,821,628, According to a Recent SEC Filing

Nancy JoAnn Johnson, Senior Vice President of Sales and Commercial Operations, on July 16, 2026, sold 14,199 shares in BillionToOne (BLLN) for $1,821,628. Following the Form 4 filing with the SEC, Johnson has control over a total of 6,900 Class A common shares of the company, with 6,900 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000207084926000044/xslF345X05/wk-form4_1784590690.xml

$BLLN
Insider Trading

Billiontoone Insider Sold Shares Worth $2,497,698, According to a Recent SEC Filing

David Tsao, Director, Chief Technology Officer, on July 13, 2026, sold 20,000 shares in Billiontoone (BLLN) for $2,497,698. Following the Form 4 filing with the SEC, Tsao has control over a total of 1,000 Class A common shares of the company, with 1,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000208712726000004/xslF345X05/wk-form4_1784147888.xml

$BLLN
Insider Trading

Billiontoone Insider Sold Shares Worth $533,330, According to a Recent SEC Filing

John Roderick ten Bosch, Senior Vice President, Laboratory Operations, on July 13, 2026, sold 4,251 shares in Billiontoone (BLLN) for $533,330. Following the Form 4 filing with the SEC, ten Bosch has control over a total of 29,301 Class A common shares of the company, with 29,301 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000208712626000006/xslF345X05/wk-form4_1784147901.xml

$BLLN
Insider Trading

Billiontoone Insider Sold Shares Worth $1,000,000, According to a Recent SEC Filing

Shan Riku Sakakibara, Chief Product Officer, on July 09, 2026, sold 8,000 shares in Billiontoone (BLLN) for $1,000,000. Following the Form 4 filing with the SEC, Sakakibara has control over a total of 204,000 Class A common shares of the company, with 204,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000208854726000006/xslF345X05/wk-form4_1783975155.xml

$BLLN
Insider Trading

Billiontoone Insider Sold Shares Worth $1,576,276, According to a Recent SEC Filing

Oguzhan Atay, Director, Chairman, and CEO, on July 09, 2026, sold 12,500 shares in Billiontoone (BLLN) for $1,576,276.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000208854926000006/xslF345X05/wk-form4_1783975174.xml

$BLLN
Insider Trading

Billiontoone Insider Sold Shares Worth $2,045,326, According to a Recent SEC Filing

David Tsao, Director, Chief Technology Officer, on June 15, 2026, sold 20,000 shares in Billiontoone (BLLN) for $2,045,326. Following the Form 4 filing with the SEC, Tsao has control over a total of 1,000 Class A common shares of the company, with 1,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000208712726000002/xslF345X05/wk-form4_1781732827.xml

$BLLN
Insider Trading

Billiontoone Insider Sold Shares Worth $287,363, According to a Recent SEC Filing

John Roderick ten Bosch, Senior Vice President of Laboratory Operations, on June 15, 2026, sold 2,832 shares in Billiontoone (BLLN) for $287,363. Following the Form 4 filing with the SEC, ten Bosch has control over a total of 34,968 Class A common shares of the company, with 34,968 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2070849/000208712626000002/xslF345X05/wk-form4_1781732836.xml

$BLLN

Track with the FINWIRES app suite

FolioX
FolioX
Track BLLN in your portfolio
WheelAI
WheelAI
Analyze BLLN options with the wheel strategy
StockInsider
StockInsider
See market sentiment on BLLN